Looking forward into Fy22 - US ACV $21.0m with Revenue of US$15.6, Gross Profit US $14.2, EBITDA $6.4m, NPAT $4.5m / EPS of 0.7c per share.
Convert USD to AUD $. Assume 74c for this exercise
Fy22 - AUD $ ACV $28.3m with Revenue of AUD $21.08, Gross Profit US $19.1 EBITDA $8.6m, NPAT $6.08m / EPS of 0.94c per
... the same goes for Quarter on Quarter Comparison. Put 74c exchange rate and there's a material uplift - eg Q4 - ACV AUD $13.24
On market value, RaaS use a WACC 14% (very conservative) and that delivers an NPV of .94c
If over the next 12 months they hit expectations, then a lower WACC is justified. eg WACC of 10% NPV, there is a material uplift in NPV.
Summary
Don't sweat the small stuff.
Looking forward into Fy22 - US ACV $21.0m with Revenue of...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
